Cindy Liu
Director, Molecular Analytical Development Prime Medicine
Cindy Liu, Director of Molecular Analytical Development at Prime Medicine, is an experienced leader in gene and cell therapy analytics. She specializes in sequencing-based methods to characterize rAAV, LNP, and ex vivo cell therapy products, with a focus on ensuring genomic integrity and product quality. Cindy has led analytical development efforts supporting IND-enabling programs and is known for driving cross-functional collaboration across R&D, CMC, and regulatory teams to advance innovative therapies toward the clinic.
Seminars
Tuesday 29th September 2026
Panel Discussion: Advancing Scalable Gene Editing Manufacturing & CDMO Collaboration to Preserve Product Quality & Reduce Timelines
1:30 pm
- Streamlining manufacturing and analytical collaboration to preserve product purity, potency, and consistency throughout scale-up
- Optimizing CDMO partnerships and tech transfer strategies to reduce development delays and manufacturing inefficiencies
- Exploring flexible guide RNA manufacturing approaches to support scalable production across diverse rare disease populations
